Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 23.

Maurer, M A; Tuller, F; Gredler, V; Berger, T; Lutterotti, A; Lünemann, J D; Reindl, M (2016). Rituximab induces clonal expansion of IgG memory B-cells in patients with inflammatory central nervous system demyelination. Journal of Neuroimmunology, 290:49-53.

Comabella, M; Kakalacheva, K; Río, J; Münz, C; Montalban, X; Lünemann, J D (2012). EBV-specific immune responses in patients with multiple sclerosis responding to IFNβ therapy. Multiple Sclerosis, 18(5):605-609.

Lünemann, J D (2012). Epstein-Barr virus in multiple sclerosis: A continuing conundrum. Neurology, 78(1):11-12.

Jelcic, I; Hsu, K C; Kakalacheva, K; Breiden, P; Dupont, B; Uhrberg, M; Martin, R; Münz, C; Lünemann, J D (2012). Killer immunoglobulin-like receptor locus polymorphisms in multiple sclerosis. Multiple Sclerosis, 18(7):951-958.

Keller, C W; Fokken, C; Turville, S G; Lünemann, A; Schmidt, J; Münz, C; Lünemann, J D (2011). TNF-{alpha} induces macroautophagy and regulates MHC class II expression in human skeletal muscle cells. Journal of Biological Chemistry, 286(5):3970-3980.

Kakalacheva, K; Lünemann, J D (2011). Environmental triggers of multiple sclerosis. FEBS Letters, 585(23):3724-3729.

Nimmerjahn, F; Lünemann, J D (2011). Expression and function of the inhibitory Fcγ-receptor in CIDP. Journal of the Peripheral Nervous System, 16 Sup:41-44.

Lünemann, A; Tackenberg, B; DeAngelis, T; da Silva, R B; Messmer, B; Vanoaica, L D; Miller, A; Apatoff, B; Lublin, F D; Lünemann, J D; Münz, C (2011). Impaired IFN-γ production and proliferation of NK cells in multiple sclerosis. International Immunology, 23(2):139-148.

Kakalacheva, K; Maurer, M A; Tackenberg, B; Münz, C; Willcox, N; Lünemann, J D (2011). Intrathymic Epstein-Barr virus infection is not a prominent feature of myasthenia gravis. Annals of Neurology, 70(3):508-514.

Kakalacheva, K; Münz, C; Lünemann, J D (2011). Viral triggers of multiple sclerosis. Biochimica et Biophysica Acta, 1812(2):132-140.

Comabella, M; Montalban, X; Horga, A; Messmer, B; Kakalacheva, K; Strowig, T; Caballero, E; Münz, C; Lünemann, J D (2010). Antiviral immune response in patients with multiple sclerosis and healthy siblings. Multiple Sclerosis, 16(3):355-358.

Klein, L; Münz, C; Lünemann, J D (2010). Autophagy-mediated antigen processing in CD4(+) T cell tolerance and immunity. FEBS Letters, 584(7):1405-1410.

Comabella, M; Montalban, X; Kakalacheva, K; Osman, D; Nimmerjahn, F; Tintoré, M; Lünemann, J D (2010). B cell expression of the inhibitory Fc gamma receptor is unchanged in early MS. Journal of Neuroimmunology, 223(1-2):135-137.

Lünemann, J D; Tackenberg, B; Stein, A; Wandinger, K P; Oertel, W H; Wagner, H J; Münz, C; Meisel, H; Sommer, N; Zipp, F (2010). Dysregulated Epstein-Barr virus infection in patients with CIDP. Journal of Neuroimmunology, 218(1-2):107-111.

Lünemann, J D; Tintoré, M; Messmer, B; Strowig, T; Rovira, A; Perkal, H; Caballero, E; Münz, C; Montalban, X; Comabella, M (2010). Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis. Annals of Neurology, 67(2):159-169.

Tackenberg, B; Nimmerjahn, F; Lünemann, J D (2010). Mechanisms of IVIG efficacy in chronic inflammatory demyelinating polyneuropathy. Journal of Clinical Immunology, 30(Sup 1):S65-S69.

Comabella, M; Montalban, X; Münz, C; Lünemann, J D (2010). Targeting dendritic cells to treat multiple sclerosis. Nature Reviews. Neurology, 6(9):499-507.

Münz, C; Lünemann, J D; Getts, M T; Miller, S D (2009). Antiviral immune responses: triggers of or triggered by autoimmunity? Nature Reviews. Immunology, 9(4):246-258.

Lünemann, J D; Münz, C (2009). EBV in MS: guilty by association? Trends in Immunology, 30(6):243-248.

Lünemann, A; Lünemann, J D; Münz, C (2009). Regulatory NK-cell functions in inflammation and autoimmunity. Molecular Medicine, 15(9-10):352-358.

Lünemann, J D; Jelcic, I; Roberts, S; Lutterotti, A; Tackenberg, B; Martin, R; Münz, C (2008). EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2. Journal of Experimental Medicine, 205(8):1763-1773.

Lünemann, J D; Huppke, P; Roberts, S; Brück, W; Gärtner, J; Münz, C (2008). Broadened and elevated humoral immune response to EBNA1 in pediatric multiple sclerosis. Neurology, 71(13):1033-1035.

Lünemann, A; Lünemann, J D; Roberts, S; Messmer, B; Barreira da Silva, R; Raine, C S; Münz, C (2008). Human NK cells kill resting but not activated microglia via NKG2D- and NKp46-mediated recognition. Journal of Immunology, 181(9):6170-6177.

This list was generated on Mon Oct 23 12:57:25 2017 CEST.